The length of survival of patients with mid-to-late stage cervical cancer mainly depends on the patient’s sensitivity to radiotherapy, targeted therapy, immunotherapy, and whether distant metastasis occurs. When cervical cancer reaches the middle and late stages, patients usually show irregular vaginal bleeding and fluid flow. Patients with mid-stage cervical cancer who are more sensitive to radiotherapy drugs can survive for more than 5 years through active pelvic radiotherapy and targeted therapy. If cervical cancer is in advanced stage, patients have already developed distant metastasis in lung, bone, liver and other parts, radiotherapy or targeted therapy at this time usually has poorer effect, and their survival period is mostly about 1 year. Therefore, for patients with cervical cancer in the middle and late stages, it is recommended to relax and if symptoms such as nausea and vomiting occur after radiotherapy, you can take vitamin B6 and other antiemetic treatments as prescribed by the doctor.